They also frequently have neutralizing autoantibodies against IL-17A and/or IL-17F that underlie chronic mucocutaneous candidiasis, a disease that is seen in patients with inborn errors of IL-17A/F immunity4. The gene discussed is IL17A; the disease is chronic mucocutaneous candidiasis.